N-[4-(aminomethyl)-1-methylpyrazol-5-yl]-3-phenyl-1,2-thiazole-5-carboxamide;2,2,2-trifluoroacetic acid
C17H16F3N5O3S — CID 167970393
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(aminomethyl)-1-methylpyrazol-5-yl]-3-phenyl-1,2-thiazole-5-carboxamide;2,2,2-trifluoroacetic acid
N-[4-(aminomethyl)-1-methylpyrazol-5-yl]-3-phenyl-1,2-thiazole-5-carboxamide;2,2,2-trifluoroacetic acid (PubChem CID 167970393) has the molecular formula C17H16F3N5O3S and a molecular weight of 427.41 g/mol. Its IUPAC name is N-[4-(aminomethyl)-1-methylpyrazol-5-yl]-3-phenyl-1,2-thiazole-5-carboxamide;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | N-[4-(aminomethyl)-1-methylpyrazol-5-yl]-3-phenyl-1,2-thiazole-5-carboxamide;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 167970393 |
| Molecular Formula | C17H16F3N5O3S |
| Molecular Weight | 427.41 g/mol |
| Exact Mass | 427.09 |
| IUPAC Name | N-[4-(aminomethyl)-1-methylpyrazol-5-yl]-3-phenyl-1,2-thiazole-5-carboxamide;2,2,2-trifluoroacetic acid |
| SMILES | Cn1ncc(CN)c1NC(=O)c1cc(-c2ccccc2)ns1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C15H15N5OS.C2HF3O2/c1-20-14(11(8-16)9-17-20)18-15(21)13-7-12(19-22-13)10-5-3-2-4-6-10;3-2(4,5)1(6)7/h2-7,9H,8,16H2,1H3,(H,18,21);(H,6,7) |
| InChIKey | CFHBJWZQVZCPIZ-UHFFFAOYSA-N |
| XLogP | 2.89 |
| TPSA | 123.13 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.41 |
| LogP ≤ 5 | 2.89 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167970393 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.